EX-99.32 33 m71067exv99w32.htm EX-99.32 ex-99.32
Exhibit 99.32
MATERIAL CHANGE REPORT
Regulation 51-102 Respecting Continuous Disclosure Obligations
Form 51-102F3
1.   NAME AND ADDRESS OF COMPANY:
 
    THERATECHNOLOGIES INC.
2310 Alfred-Nobel Boulevard
Montreal, Québec
Canada H4S 2B4
 
2.   DATE OF MATERIAL CHANGE:
 
    June 2, 2011
 
3.   NEWS RELEASE:
 
    A news release describing this material change was issued on June 2, 2011 on “Marketwire”. A copy of the news release is available on the SEDAR website at www.sedar.com.
 
4.   SUMMARY OF MATERIAL CHANGE:
 
    On June 2, 2011, Theratechnologies Inc. (the “Corporation”) announced that it had re-evaluated its research and development business model (the “R&D Model”). The review of the R&D Model resulted in the collective dismissal of 24 employees and the Corporation estimates a reduction in payroll expenses of approximately $300,000 for the remainder of fiscal 2011 and approximately $2.5 million for fiscal 2012.
 
5.   FULL DESCRIPTION OF MATERIAL CHANGE:
 
    On June 2, 2011, the Corporation announced that it had re-evaluated its R&D Model. The Corporation intends to call upon partners in the public and private arena to help it bring its research and development project forward. The review of the R&D Model resulted in the collective dismissal of 24 employees and the Corporation estimates a reduction in payroll expenses of approximately $300,000 for the remainder of fiscal 2011 and approximately $2.5 million for fiscal 2012.
 
6.   RELIANCE ON SUBSECTION 7.1(2) OR (3) OF NATIONAL INSTRUMENT 51-102:
 
    Not applicable.
 
7.   OMITTED INFORMATION:
 
    Not applicable.

 


 

- 2 -
8.   EXECUTIVE OFFICER:
 
    For further information, contact Jocelyn Lafond, Vice President, Legal Affairs, and Corporate Secretary of the Company at (514) 336-4804, ext. 288.
 
9.   DATE OF REPORT:
 
    June 3, 2011